Rocuronium Fresenius rocuronium bromide 50mg/5mL solution for injection vial

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

지금 구매하세요

공공 평가 보고서 공공 평가 보고서 (PAR)
26-11-2017

유효 성분:

rocuronium bromide, Quantity: 10 g/L

제공처:

Fresenius Kabi Australia Pty Ltd

INN (International Name):

Rocuronium bromide

약제 형태:

Injection, solution

구성:

Excipient Ingredients: water for injections; glacial acetic acid; sodium acetate trihydrate; sodium chloride

관리 경로:

Intravenous

패키지 단위:

10 x 5mL, 5 x 5mL

처방전 유형:

(S4) Prescription Only Medicine

치료 징후:

INDICATIONS,Rocuronium is indicated as an adjunct to general anaesthesia to facilitate endotracheal intubation during routine induction, to provide muscle relaxation and to facilitate mechanical ventilation in adults, children and infants over 1 month of age.,Rocuronium is also indicated as an adjunct to general anaesthesia to facilitate endotracheal intubation during rapid sequence induction when suxamethonium is contraindicated, however, this has not been studied in infants and children.,Rocuronium is also indicated as an adjunct in the intensive care unit (ICU) to facilitate mechanical ventilation.

제품 요약:

Visual Identification: A clear, colourless to pale brownish-yellow solution.; Container Type: Vial; Container Material: Glass; Container Life Time: 24 Months; Container Temperature: Store at 2 to 8 degrees Celsius

승인 상태:

Licence status A

승인 날짜:

2014-11-12